BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PRKCA
,
Metabolism of xenobiotics
,
Hepatitis
,
Embryo
,
Metabolism of nitric oxide
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
T-cell lymphomas
NextBio Summary
General Info
Curated Studies
Most Correlated Studies
Cancer Gene Census - mutations in cancer genes
Lymph node biopsies of ALK-positive or negative anaplastic large cell lymphoma patients
OMIM - Malignant neoplasms
Canine lymphomas analyzed by breed and subtype
Cutaneous T-Cell lymphoma HuT78 cell line treated with AR-A014418 and/or Enzastaurin
Explore Curated Studies Results
Literature
Most Relevant Literature
Cost-effectiveness of brentuximab vedotin for the treatment of cutaneous T-cell lymphoma.
Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work…
Prognostic and therapeutic significance of XPO1 in T-cell lymphoma.
Follicular T-cell lymphoma.
Clonotype pattern in T-cell lymphomas map the cell of origin to immature lymphoid precursors.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Cohort of Peripheral T Cell Lymphoma
Alemtuzumab and CHOP in T-cell Lymphoma
MESA Treatment for NK/T Cell Lymphoma
Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma
Anti-Tac(Fv)-PE38 (LMB-2) to Treat Cutaneous T-Cell Lymphomas
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ